| ||||||||||||||
|
|
|||||||||||||


*Children's Hospital of Michigan, Detroit, Michigan;
Barbara Davis Center for Childhood Diabetes;
Department of Endocrinology, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center; and ¶Department of Anesthesiology, The Children's Hospital, University of Colorado Health Sciences Center, Denver, Colorado
Address correspondence and reprint requests to Zulfiqar Ahmed, MD, Staff Anesthesiologist, Children's Hospital of Michigan, 3901 Beaubien Street, Detroit, MI 48201. Address e-mail to zulfiqarahmed{at}mac.com.
The past 20 yr have seen an explosion in advances for the management of Type I diabetes mellitus. Not only new delivery systems, such as the continuous subcutaneous insulin pump, but also better and more stable types of insulin with predictable pharmacokinetics and pharmacodynamics have been developed. An artificial pancreas is now on the horizon. This progress has had a significant impact on modern perioperative care of the diabetic patient.
|